Greenebaum Cancer Center - Clinical Trials

  Clinical Trials...
     More About Clinical Trials
     Participating
     Questions to Ask
     For More Information
  Research
  Cancer Overviews
  Treatment Programs
  Physicians and Staff

Current Clinical Trials for Head and Neck

GCC 0442 - A Phase II Study of Evaluation of Cetuximab (Erbitux) and Concurrent Carboplatin, Paclitaxel & Radiotherapy in the Management of Patients With Advanced Locoregional Squamous Cell Carcinomas of the Head and Neck.

GCC 0448 - A Randomized Phase III Trial Comparing Sequential Therapy With TPF/Chemoradiation (ST) To Cisplatin-Based Chemoradiotherapy with Accelerated Concomitant Boost Radiotherapy (CRT) For Locally Advanced Squamous Cell Cancer of the Head and Neck(Abbreviated Name: The Paradigm Trial)

GCC 0608 - Intra-Tumoral Injection of Dendritic Cells as Adjuvant Therapy for Squamous Cell Carcinoma of the Head and Neck

GCC0781 - A Randomized, Open-Label Phase II Study of BIBW 2992 Versus Cetuximab (Erbitux) in Patients With Metastatic or Recurrent Head and Neck Squamous Cell Carcinoma (HNSCC) After Failure of Platinum-Containing Therapy With a Cross-Over Period for Progressing Patients



Email this Page                                                                     Print this Page

Home Site Map Disclaimer University of Maryland Greenebaum Cancer Center UM School of Medicine UM Medical System UM Medical Center Text: If you would like to make an appointment or talk to someone about our services please call 1-800-888-8823. Physicians can call our dedicated consultation referral service at 1-800-373-4111.